ABCG2 and cancer: As a potential solution, combining chemotherapeutic agents with reversal compounds that inhibit ABC transporter activity presents a promising approach to enhance the efficacy of chemotherapy in cancer patients (Li et al., 2024b; Kuhnert et al., 2024; Fu et al., 2024).